Just caught Injective making some moves after that major upgrade passed. The IIP-619 got through with basically unanimous approval, and it's actually meaningful stuff - they're improving the EVM architecture and ramping up token deflation. Price jumped to $3.60 but cooled down to around $3.27 now, so still up from where it was sitting before. What's interesting is Pineapple Financial dropped $2M to grab 7% of the total supply, so there's some serious institutional interest here. That's usually a good sign. Traders are watching for a close above $3.50 on the 4-hour to confirm a breakout - if that holds, next targets are $4.50, $5.00, and $5.50. Yeah, Injective is down 65% year-on-year, so it's risky, but the combo of the upgrade, the institutional buying, and the technical setup is interesting to watch. Could be a decent risk-reward play if you're into that.